BIO-Europe Spring® 2017: Key considerations in microbiome partnering

March 29, 2017
The human microbiome is garnering research interest across the globe and industry is responding to the growing possibilities of therapeutic developments in a variety of ways, a key aspect of which is partnerships. The current state of play means emerging companies are often looking for specific expertise or experience in their partners, often influenced by the variety of approaches under different regulatory jurisdictions or financial structures.
Previous Video
BIO-Europe Spring® 2017: Incorporating flexibility into your R&D strategy
BIO-Europe Spring® 2017: Incorporating flexibility into your R&D strategy

Strategic decisions made early in clinical development often have an impact on the downstream commercial po...

Next Video
BIO-Europe Spring® 2017: Innovation in an uncertain world
BIO-Europe Spring® 2017: Innovation in an uncertain world

In the best of times, biotech innovation is full of uncertainty. But today's political, regulatory, and soc...